CMPX
Compass Therapeutics, Inc. - Common Stock (CMPX)
$21
About Compass Therapeutics, Inc. - Common Stock (CMPX)
Compass Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of proprietary antibody therapeutics. Its platform includes common light chain-focused antibody discovery, human display for antibody tuning, stitchmabs, and highly modular and manufacturable bispecific candidates. The company was founded by Thomas J. Schuetz in 2014 and is headquartered in Boston, MA.
Details
Daily high
$2.32
Daily low
$2.20
Price at open
$2.32
52 Week High
$6.88
52 Week Low
$1.61
Market cap
428.6M
Dividend yield
-
Volume
16,556
Avg. volume
2.8M
P/E ratio
-5.91
Compass Therapeutics, Inc. - Common Stock News
Details
Daily high
$2.32
Daily low
$2.20
Price at open
$2.32
52 Week High
$6.88
52 Week Low
$1.61
Market cap
428.6M
Dividend yield
-
Volume
16,556
Avg. volume
2.8M
P/E ratio
-5.91